PDCD1 and breast cancer: For example, small-molecule nano-inhibitor targeting the PD-1/PD-L1 axis (BMS202) mediates ICI and PDT synergistically in the therapy of breast cancer, leading to primary tumor regression and reducing the occurrence of lung metastasis [427].